| 1 |
Wark P. Bronchitis (acute) [J]. BMJ Clin Evid, 2015: pii: 1508.
|
| 2 |
Kinkade S, Long NA. Acute Bronchitis[J]. Am Fam Physician, 2016, 94(7): 560-565.
|
| 3 |
Albert RH. Diagnosis and treatment of acute bronchitis[J]. Am Fam Physician, 2010, 82(11): 1345-1350.
|
| 4 |
Little P, Rumsby K, Kelly J, et al. Information leaflet and antibiotic prescribing strategies for acute lower respiratory tract infection: a randomized controlled trial[J]. JAMA, 2005, 293(24): 3029-3035.
|
| 5 |
Linder JA, Sim I. Antibiotic treatment of acute bronchitis in smokers：a systematic review[J]. J Gen Intern Med, 2002, 17(3): 230-234.
|
| 6 |
Brereton CJ, Lennon D, Browning S, et al. Is gentamicin safe and effective for severe community-acquired pneumonia? An 8-year retrospective cohort study[J]. Int J Antimicrob Agents, 2018, 51(6): 862-866.
|
| 7 |
Hayward RS, Harding J, Molloy R, et al. Adverse effects of a single dose of gentamicin in adults: a systematic review[J]. Br J Clin Pharmacol, 2018, 84(2): 223-238.
|
| 8 |
Gyetvai B, Jerzsele Á, Pászti-Gere E, et al. Gentamicin sulphate permeation through porcine intestinal epithelial cell monolayer[J]. Acta Vet Hung, 2015, 63(1): 60-68.
|
| 9 |
McKenzie HC 3rd, Murray MJ, Concentrations of gentamicin in serum and bronchial lavage fluid after intravenous and aerosol administration of gentamicin to horses[J]. Am J Vet Res, 2000, 61(10): 1185-1190.
|
| 10 |
Lin HC, Cheng HF, Wang CH, et al. Inhaled gentamicin reduces airway neutrophil activity and mucus secretion in bronchiectasis[J]. Am J Respir Crit Care Med, 1997, 155(6): 2024-2029.
|
| 11 |
Park SW, Park JS, Lee YM, et al. Differences in radiological/HRCT findings in eosinophilic bronchitis and asthma: implication for bronchial responsiveness[J]. Thorax, 2006, 61(1): 41-47.
|
| 12 |
Zhang Y, Zhang ZR. Simple determination of terbutaline in dog plasma by column-switching liquid chromatography[J]. J Chromatogr B Analyt Technol Biomed Life Sci, 2004, 805(2): 211-214.
|
| 13 |
Hvizdos KM, Jarvis B. Budesonide inhalation suspension: a review of its use in infants, children and adults with inflammatory respiratory disorders[J]. Drugs, 2000, 60(5): 1141-1178.
|
| 14 |
Bian F, Wu YE, Zhang CL. Use of aerosol inhalation treatment with budesonide and terbutaline sulfate on acute pediatric asthmatic bronchitis[J]. Exp Ther Med, 2017, 14(2): 1621-1625.
|
| 15 |
Hashemian SM, Mortaz E, Jamaati H, et al. Budesonide facilitates weaning from mechanical ventilation in difficult-to-wean very severe COPD patients: Association with inflammatory mediators and cells[J]. J Crit Care, 2018, 44: 161-167.
|
| 16 |
Wenzel S, Castro M, Corren J, et al. Dupilumab efficacy and safety in adults with uncontrolled persistent asthma despite use of medium-to-high-dose inhaled corticosteroids plus a long-acting beta2 agonist: a randomised double-blind placebo-controlled pivotal phase 2b dose-ranging trial[J]. Lancet, 2016, 388(10039): 31-44.
|
| 17 |
Selek H, Sahin S, Ercan MT, et al. Formulation and in vitro/in vivo evaluation of terbutaline sulphate incorporated in PLGA (25/75) and L-PLA microspheres[J]. J Microencapsul, 2003, 20(2): 261-271.
|
| 18 |
Baer B, Veldhuizen EJA, Possmayer F, et al. The wet bridge transfer system: a novel tool to assess exogenous surfactant as a vehicle for intrapulmonary drug delivery[J]. Discov Med, 2018, 26(144): 207-218.
|
| 19 |
Edsbäcker S1, Brattsand R. Budesonide fatty-acid esterification: a novel mechanism prolonging binding to airway tissue. Review of available data[J]. Ann Allergy Asthma Immunol, 2002, 88(6): 609-616.
|
| 20 |
Jendbro M, Johansson CJ, Strandberg P, et al. Pharmacokinetics of budesonide and its major ester metabolite after inhalation and intravenous administration of budesonide in the rat[J]. Drug Metab Dispos, 2001, 29(5): 769-776.
|
| 21 |
Brattsand R, Miller-Larsson A. The role of intracellular esterification in budesonide once-daily dosing and airway selectivity[J]. Clin Ther, 2003, 25 Suppl C: C28-C41.
|
| 22 |
Miller-Larsson A, Jansson P, Runström A, et al. Prolonged airway activity and improved selectivity of budesonide possibly due to esterification[J]. Am J Respir Crit Care Med, 2000, 162(4 Pt 1): 1455-1461.
|
| 23 |
Sosnowski TR. Selected Engineering and Physicochemical Aspects of Systemic Drug Delivery by Inhalation[J]. Curr Pharm Des, 2016, 22(17): 2453-2462.
|
| 24 |
Hu X, Yang FF, Liao YH. Pharmacokinetic Considerations of Inhaled Pharmaceuticals for Systemic Delivery[J]. Curr Pharm Des, 2016, 22(17): 2532-2548.
|
| 25 |
Miller-Larsson A, Mattsson H, Hjertberg E, et al. Reversible fatty acid conjugation of budesonide. Novel mechanism for prolonged retention of topically applied steroid in airway tissue[J]. Drug Metab Dispos, 1998, 26(7): 623-630.
|
| 26 |
van Velzen AJ, Uges JWF, Heijerman HGM, et al. Pharmacokinetics and safety of tobramycin nebulization with the I-neb and PARI-LC Plus in children with cystic fibrosis: A randomized, crossover study[J]. Br J Clin Pharmacol, 2019, 85(9): 1984-1993.
|
| 27 |
韩振华. 超声雾化与空气压缩雾化泵雾化吸入治疗小儿哮喘的临床观察[J]. 山西医药杂志，2011, 40(02): 165-166.
|
| 28 |
Coates AL, Green M, Leung K, et al. A comparison of amount and speed of deposition between the PARI LC STAR(R) jet nebulizer and an investigational eFlow(R) nebulizer[J]. J Aerosol Med Pulm Drug Deliv, 2011, 24(3): 157-163.
|
| 29 |
陈先华. 硫酸庆大霉素雾化吸入佐治急性支气管炎的临床疗效观察[J/CD]. 中华肺部疾病杂志(电子版), 2012, 5(2): 133-136.
|